112 related articles for article (PubMed ID: 35924809)
1. Regulation of p53 and survivin by Curcuma longa extract to caspase-3 dependent apoptosis in triple negative breast cancer cells.
Anggia Paramita D; Hermansyah D; Anggia Paramita D; Amalina ND
Med Glas (Zenica); 2022 Aug; 19(2):. PubMed ID: 35924809
[TBL] [Abstract][Full Text] [Related]
2. Regulation of p53 and survivin by prodigiosin compound derived from Serratia marcescens contribute to caspase-3-dependent apoptosis in acute lymphoblastic leukemia cells.
Sam MR; Pourpak RS
Hum Exp Toxicol; 2018 Jun; 37(6):608-617. PubMed ID: 28681618
[TBL] [Abstract][Full Text] [Related]
3. Combination Curcuma longa and Phyllanthus niruri Extract Potentiate Antiproliferative in Triple Negative Breast Cancer MDAMB-231 Cells.
Hermansyah D; Anggia Paramita D; Paramita DA; Amalina ND
Asian Pac J Cancer Prev; 2023 May; 24(5):1495-1505. PubMed ID: 37247268
[TBL] [Abstract][Full Text] [Related]
4. Fish-Oil-Derived DHA-mediated Enhancement of Apoptosis in Acute Lymphoblastic Leukemia Cells is Associated with Accumulation of p53, Downregulation of Survivin, and Caspase-3 Activation.
Sam MR; Esmaeillou M; Shokrgozar MA
Nutr Cancer; 2017 Jan; 69(1):64-73. PubMed ID: 27880058
[TBL] [Abstract][Full Text] [Related]
5. Modulating Survivin as a Radioresistant Factor, Caspase-3, and Apoptosis by Omega-3 Docosahexaenoic Acid Sensitizes Mutant-p53 Colorectal Cancer Cells to γ-Irradiation.
Hosseini F; Sam MR; Jabbari N; Mozdarani H
Cancer Biother Radiopharm; 2018 Nov; 33(9):387-395. PubMed ID: 30395490
[TBL] [Abstract][Full Text] [Related]
6. Fish-oil-derived eicosapentaenoic acid decreases survivin expression and induces wt-p53 accumulation with caspase-3 activation in acute lymphoblastic leukemia cells.
Sam MR; Esmaeillou M; Sam S; Shokrgozar MA
Hum Exp Toxicol; 2018 Jul; 37(7):714-724. PubMed ID: 28920465
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acid DHA modulates p53, survivin, and microRNA-16-1 expression in KRAS-mutant colorectal cancer stem-like cells.
Sam MR; Tavakoli-Mehr M; Safaralizadeh R
Genes Nutr; 2018; 13():8. PubMed ID: 29619114
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
[TBL] [Abstract][Full Text] [Related]
9. Mitotic arrest and apoptosis in breast cancer cells induced by Origanum majorana extract: upregulation of TNF-α and downregulation of survivin and mutant p53.
Al Dhaheri Y; Eid A; AbuQamar S; Attoub S; Khasawneh M; Aiche G; Hisaindee S; Iratni R
PLoS One; 2013; 8(2):e56649. PubMed ID: 23451065
[TBL] [Abstract][Full Text] [Related]
10. YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation.
Pennati M; Sbarra S; De Cesare M; Lopergolo A; Locatelli SL; Campi E; Daidone MG; Carlo-Stella C; Gianni AM; Zaffaroni N
Int J Cancer; 2015 Jan; 136(2):299-309. PubMed ID: 24866585
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1α/miR-494/Survivin signaling pathway.
Li H; Sun X; Li J; Liu W; Pan G; Mao A; Liu J; Zhang Q; Rao L; Xie X; Sheng X
Neoplasia; 2022 Oct; 32():100821. PubMed ID: 35985176
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor activities of sepantronium bromide (YM155), a survivin suppressant, in combination with microtubule-targeting agents in triple-negative breast cancer cells.
Kaneko N; Yamanaka K; Kita A; Tabata K; Akabane T; Mori M
Biol Pharm Bull; 2013; 36(12):1921-7. PubMed ID: 24432379
[TBL] [Abstract][Full Text] [Related]
13. Effective Targeting Survivin, Caspase-3 and MicroRNA-16-1 Expression by Methyl-3-pentyl-6-methoxyprodigiosene Triggers Apoptosis in Colorectal Cancer Stem-Like Cells.
Sam S; Sam MR; Esmaeillou M; Safaralizadeh R
Pathol Oncol Res; 2016 Oct; 22(4):715-23. PubMed ID: 27055667
[TBL] [Abstract][Full Text] [Related]
14. The histone deacetylase inhibitor OBP-801 and eribulin synergistically inhibit the growth of triple-negative breast cancer cells with the suppression of survivin, Bcl-xL, and the MAPK pathway.
Ono H; Sowa Y; Horinaka M; Iizumi Y; Watanabe M; Morita M; Nishimoto E; Taguchi T; Sakai T
Breast Cancer Res Treat; 2018 Aug; 171(1):43-52. PubMed ID: 29752686
[TBL] [Abstract][Full Text] [Related]
15. The Role of Apoptotic Genes and Protein-Protein Interactions in Triple-negative Breast Cancer.
Adinew GM; Messeha S; Taka E; Ahmed SA; Soliman KFA
Cancer Genomics Proteomics; 2023; 20(3):247-272. PubMed ID: 37093683
[TBL] [Abstract][Full Text] [Related]
16. Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line.
Chang E; Donahue J; Smith A; Hornick J; Rao JN; Wang JY; Battafarano RJ
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):225-32. PubMed ID: 20236666
[TBL] [Abstract][Full Text] [Related]
17. Expression of survivin and p53 modulates honokiol-induced apoptosis in colorectal cancer cells.
Lai YJ; Lin CI; Wang CL; Chao JI
J Cell Biochem; 2014 Nov; 115(11):1888-99. PubMed ID: 24905183
[TBL] [Abstract][Full Text] [Related]
18. Significance of combined TGF-β1 and survivin expression on the prognosis of patients with triple-negative breast cancer.
Liu N; Qi D; Jiang J; Zhang J; Yu C
Oncol Lett; 2022 Jun; 23(6):193. PubMed ID: 35527782
[TBL] [Abstract][Full Text] [Related]
19. α-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple-negative human breast cancer cells via activating p73.
Tiwary R; Yu W; Sanders BG; Kline K
Breast Cancer Res; 2011 Jan; 13(1):R1. PubMed ID: 21214929
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling.
Tan X; Kong D; Tao Z; Cheng F; Zhang B; Wang Z; Mei Q; Chen C; Wu K
Biomark Res; 2024 Jan; 12(1):13. PubMed ID: 38273343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
